Cisplatin Liposomal clinical trials
A product of Cisplatin; its studies count on that page too.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 1999
How each study uses Cisplatin Liposomal is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 19 Dec 1978 · PLATINOL-AQ · NDA 018057 (FDA, Drugs@FDA; as Cisplatin)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Cisplatin liposomal
- 2
Studies by the year they started
3 studies that test it; most in 1999 (1)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2005 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Insmed Incorporated (1) · NYU Langone Health (1) · Centre Hospitalier Universitaire Vaudois (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Cisplatin
Studies
Open first, then newest update. How each study uses Cisplatin Liposomal is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Photo-induction as a Means to Improve Cisplatin Delivery to Pleural MalignanciesTerminatedPhase 1Centre Hospitalier Universitaire VaudoisNCT02702700Written as Cisplatin, liposomalHow we know
- Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the LungCompletedPhase 1/2Insmed IncorporatedNCT00102531Written as Cisplatin liposomalHow we know
- Liposomal Cisplatin in Treating Patients With Recurrent Ovarian CancerCompletedPhase 2NYU Langone HealthNCT00004083Written as cisplatin liposomalHow we know